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N E W S L E T T E R
GLOBAL BUDGET REVENUE AND 
POPULATION HEALTH: MARYLAND’S 
RESPONSE TO THE NEW MODEL 
AGREEMENT WITH CMS
Hospitals across the country have been under increasing pressure to cut costs, 
but Maryland’s new Global Budget agreement with CMS has put a spotlight on the 
state’s hospitals which may feel as though they are the subject of significant scrutiny 
as they make efforts to comply with the agreement.  Peter Parvis is a lawyer who 
represents hospitals, and other health care organizations on corporate and health 
care regulatory matters. Here he explains Maryland’s new hospital reimbursement 
agreement with CMS and implications for healthcare services provided both in 
hospitals and in the community.
Background 
Maryland is the only state where hospitals are not 
reimbursed for Medicare covered patients using the 
inpatient (diagnostic-related group) and outpatient 
prospective payment systems. The State of Maryland 
has operated its acute care hospitals under a unique 
statewide rate regulated system (“the waiver”) since 
1977, under which Medicare paid acute care hospitals 
at rates set by a state agency—the Health Services 
Cost Review Commission (HSCRC)—instead 
of making payments under traditional Medicare 
methodology.  At around that time, waivers to 
Maryland and a few other states were granted by CMS 
to allow them to experiment with setting hospital 
rates.  In order to secure the waiver, rates at each hospital in Maryland had to be 
approximately the same for all payors: Medicare, Medicaid, commercial insurers, 
private payors and the uninsured (hence the term “All Payor”). Each hospital’s 
payment rates were based on historical cost data, the health status of the patient 
population served, and the level of uncompensated care provided to that population. 
In order to maintain the waiver, the state was required to keep the growth in Medicare 
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payments per inpatient case below the 
growth of inpatient Medicare costs 
nationally.1   
For over 30 years, using this all 
payor model, Maryland was able to 
successfully control the growth in per 
admission hospital costs relative to 
the nation.  While the system worked 
well for three decades, incentives 
established by the waiver, as well 
as hospital efforts toward better 
population health (consistent with the 
Affordable Care Act), pushed hospitals 
to provide more outpatient care. This 
change in the site of care increased 
the intensity and costs of inpatient 
services. As a result, Maryland was 
unable to keep its cost growth rate 
below the national average.  
The New Waiver
 Facing the reality that it could 
not continue to meet the statutory 
requirement to maintain its waiver, 
the State negotiated for a replacement 
for the waiver.2 The five-year Model 
Agreement became effective January 
1, 2014 and ends on December 31, 
2018.  
The Model Agreement is essentially 
a cap on the increase in per capita 
hospital expenditures. Under the old 
model, the focus was on controlling 
increases in Medicare inpatient 
payments per case. However, the 
new model “focuses on controlling 
increases in total hospital revenue per 
capita.”3  Under the new methodology, 
the Commission prospectively 
establishes a fixed annual revenue cap 
for each hospital. 
The Challenge for Maryland: 
Controlling Utilization
The cap requires Maryland hospitals 
to control hospital spending on a per 
capita basis for both Medicare and all 
other patients.  Since Medicare pays 
a much greater portion of the cost 
of uncompensated care in Maryland 
than in the rest of the country, hospital 
charges in Maryland to Medicare 
patients are generally higher than 
Medicare payments in the rest of the 
country.  While Maryland hospitals 
charge all patients, regardless of the 
payor, the same rates, elsewhere, 
hospitals get paid a fixed amount (with 
variances for labor costs and various 
other add-ons) for each Medicare 
admission, emergency department 
visit, or outpatient service depending 
on its coding.  That payment is 
frequently lower than payments by 
other insurance despite the fact that 
Medicare beneficiaries use hospital 
care at disproportionately higher 
levels.  Maryland hospitals charge for 
the services used at approved rates 
per unit of service.  As a result, the 
only way Maryland could achieve 
the necessary results for the new 
Model would be to control hospital 
utilization.  The issue was, how?
The State’s response was a new total 
revenue approach.  Trying to save 
money by paying less for each service 
on a per service basis—the model 
Medicare uses everywhere else and 
for physician services—ends up with 
providers providing more services 
to make up for reduced revenue per 
case/visit/test.  Maryland tackled 
revenue reduction by capping the total 
revenue each hospital could collect 
in any given year through one of two 
similar mechanisms—Total Patient 
Revenue (basically for rural or smaller 
hospitals); or Global Budget Revenue 
(GBR, for every other hospital).  A 
hospital’s total revenue in any year 
is set in advance.  It is adjusted for 
increases in population in its defined 
service area.  If its market share 
increases in its service area (the goal 
of every marketing effort by every 
hospital everywhere else), it does not 
get to keep the increased revenue. 
Under the GBR, hospitals are 
encouraged to jump start population 
health efforts to provide more care 
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outside the walls of the hospital 
setting, as long as that care is likely 
to reduce hospital utilization and cost 
—whether in the E.D., outpatient, or 
inpatient admissions.4 The challenge 
is stark—how to get physicians, 
who refer patients, and the patients 
themselves to accept as a premise 
that “Less is More.” Worse, the 
federal government has a panoply of 
statutes that are designed to prevent 
the payment of financial incentives 
to physicians to reduce services to 
Medicare patients (generally called 
gain sharing), and the State to date 
has not received a waiver from these 
statutes.5 Moreover, a hospital gets 
no credit for the simple expedient of 
shifting services outside the hospital 
setting.  Any such attempt has to be 
reported and results in a reduction of 
the GBR total revenue so that total 
costs do not increase when expensive 
hospital services are moved to less 
expensive non-hospital settings.
Under Maryland law, hospitals 
must charge every patient for all 
services used at rates approved by the 
Commission (within corridors for over 
and undercharges).  It would seem 
that providing less service to keep 
costs down would reduce utilization, 
but it is not that simple.6  The GBR is 
also tied to other initiatives such as 
to reduce readmissions to the hospital 
within 30 days, to reduce hospital 
acquired conditions and to reduce 
potentially avoidable utilization.  
Therefore, hospitals are punished 
financially if they reduce the level of 
services but there is a readmission 
within 30 days or a hospital acquired 
condition.  
The challenge is to reduce utilization 
in a system where every other player 
in the health care industry is incented 
to provide more volume to generate 
more revenue.  The task is enormous, 
especially given that the Commission 
only regulates hospitals and not 
physicians. Hospitals have engaged 
in a wide variety of efforts to improve 
care at the community level, using 
caseworkers to follow the patient 
post discharge, creating programs 
focused on high utilization diseases 
(diabetes, COPD, and hypertension 
are favorites), establishing outreach 
programs (frequently involving 
non-medical or volunteer personnel) 
as well as medical home projects, 
integrated case management intended 
to avoid duplication as a result of 
lack of information, and efforts to 
get the patient invested in their own 
healthcare.  However, since federal 
and State laws meant to prohibit 
undue influence by hospitals over 
referring physicians remain in effect, 
it is difficult to financially incentivize 
physicians and other providers to do 
less.  Of course, the State argues that 
the goal is not to do less, but only to 
eliminate services that may not be 
necessary for the well-being of the 
patient.  Regardless of the view, “less 
is more” is not universally accepted.
As a result, the total spending 
per Medicare beneficiary presents 
problems, which was foreseeable in 
that the State only regulates hospital 
revenue, and hospital revenue is not 
the majority of health care spending.7 
Since other provider costs are paid in 
the same manner in Maryland as in 
the rest of the country, utilization is 
the issue in controlling these costs, 
but unlike GBR for hospitals, there is 
no financial approach to incentivize 
all of the providers to work to reduce 
utilization.8 The jury is still out on 
the new Model and on GBR, but the 
results have been promising in the 
first two and a half years of the new 
Model Agreement, at least as far as 
controlling the increase in hospital 
spending per capita, reducing the 
Hospital Acquired Conditions Rate, 
and producing Medicare savings (over 
$300 million in the first two years). 
While challenges remain, the State 
is supposed to apply for a Phase II 
five-year Model in 2017, which at a 
minimum is supposed to cover more 
services, with the goal of covering all 
healthcare services.
   
Peter P. Parvis, J.D., Principal 
Miles & Stockbridge P.C.
ENDNOTES
1 Under section 1814(b)(3) of the Social 
Security Act; the statutory requirement 
focused on the rate of increase in 
Medicare payments to Maryland vs. the 
rest of the country.
2 The HSCRC negotiated for this waiver 
replacement with the Centers for 
Medicare and Medicaid Innovation, an 
entity under the Centers for Medicare 
and Medicaid Services that was created 
by the Affordable Care Act.
3 It requires the State to keep its increase 
in cumulative annual all-payer per 
capita total hospital revenue growth 
for Maryland residents receiving care 
at regulated Maryland hospitals to less 
than or equal to Maryland’s ten-year 
growth in gross state revenue.  
4 The Commission explains: GBR and 
TPR agreements prospectively establish 
a fixed annual revenue cap for each 
hospital to encourage them to focus on 
care improvement and population-based 
health management. From Report to the 
Governor FY 2015. The HSCRC is in 
the process of putting all hospitals on 
the GBR.
5 These waivers are available for 
accountable care organizations under the 
Medicare Shared Savings Programs.
6 The HSCRC’s premise is that 
all hospitals have to do is reduce 
unnecessary utilization, which includes 
readmissions, potentially preventable 
conditions and hospital acquired 
conditions.
7At $972 billion in 2014, it is the biggest 
single expenditure, compared to $802 
billion for physicians, dentists and other 
professional care; $400 billion for drugs 
and supplies, and $389 billion for home 
health and nursing home care nationally 
in 2014.  Medicare accounts for 20% 
of total healthcare spending.  Source: 
National Health Expenditure 2014 
Highlights.
8The HSCRC has been working with 
hospitals and other constituencies to 
develop approaches that will permit 
hospitals to incentivize physicians 
to participate in utilization reduction 
approaches, and to present its proposal 
for the 2019-2023 time frame, but those 
have not yet been formalized.
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to hospice patients living in the inner 
city.  He has lectured extensively in 
international and national settings and 
has published five books on end-of-
life care, which have been reviewed as 
“breaking new ground,” and “destined 
to become a landmark in the death 
and dying literature.” His most recent 
work is exploring what it is like to 
live and die in urban poverty and the 
challenges providers face when caring 
for vulnerable populations that live 
and die at the margins of society.
   David’s plans for program 
development at AAMC are focusing 
on “bringing clinical ethics upstream,” 
whereby ethics awareness and 
capability can be more broadly 
disseminated in patient care. This 
includes implementing an ethics 
screening for all patients admitted 
into the hospital so as to identify 
issues earlier. A contingent of “ethics 
ambassadors” are being identified and 
trained and will be present on each 
unit throughout the hospital to assist 
in identifying and resolving issues 
related to clinical conflict earlier and 
more systematically. In addition, 
he is working at establishing Unit 
Based Ethics Rounds (UBER), 
whereby the ethics team conducts 
hour-long, weekly rounds for 
each of the relevant units—on the 
unit itself. The program is being 
developed with explicit concern for 
addressing issues related to moral 
distress, compassion fatigue, and 
demoralization of clinical caregivers 
in addition to its focus on clinical 
conflict resolution.
   Born in New York City and 
having spent so many years in 
the Midwest, David is delighted to 
be returning to the East Coast, and 
in the interest of full disclosure, he 
must declare that he is a diehard NY 
Yankees fan, which has been a difficult 
thing lately, as in recent years the 
Yankees have performed in most “un-
Yankee-like” fashion.
INTRODUCING … DAVID MOLLER, DIRECTOR OF HEALTH 
CARE ETHICS, ANNE ARUNDEL MEDICAL CENTER 
David Wendell Moller arrived at Anne 
Arundel Medical Center on June 1 
to develop a program in health care 
ethics. He comes to Maryland after a 
long bioethics career in the Midwest. 
We share his brief bio here by way 
of introduction, and hope you join us 
in welcoming him back to the East 
Coast and to our health care ethics 
community. 
   David earned his PhD in 
Sociomedical Sciences from 
Columbia University.  He spent 
twenty years at Indiana University 
where he was a faculty member 
in the Schools of Liberal Arts and 
Medicine. He was one of the core 
medical ethics faculty members at 
IU, and directed the community 
outreach and educational programs 
for the palliative care team at 
Wishard Health Services (now 
Eskenazi Health).  While at 
Indiana University he received the 
system-wide President’s Award for 
Distinguished Teaching and the 
Outstanding Resident Faculty Award, 
as well as numerous Trustees Awards 
for Teaching Excellence. He most 
recently served as Senior Director 
of the Office of Human Values at 
Truman Medical Center in Kansas 
City where he pioneered an innovative 
curriculum in diversity and cultural 
competence for internal medicine 
residents, which included home visits 
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MY PATIENT
Reflective MedEd Blog
This essay was posted on August 9, 2016, on the Reflective MedEd blog, which 
is supported by the Ralph P. Leischner, Jr., MD, Department of Medical Education 
at Loyola University Chicago Stritch School of Medicine. It is published here with 
permission. To read other entries or to submit your own blog post, visit https://
reflectivemeded.org/. 
The student used the phrase “my patient” six times during the brief patient 
interaction: “I don’t like my patients to not exercise.”  “I like it when my patients 
eat healthy.”  “I like it when my patients take their medications” and so on.  Many 
students use this phrase occasionally, but this was striking.  I wondered what his 
motivation was.  Was he nervous?  Or did he think the patients were his?  After the 
interaction, I debriefed with him, asking him what went well and what he could improve. He did not bring up his use 
of “my patient” so I did.  He was unaware of his saying “my patient” and could not reflect on why he was doing so.  I 
asked him what he thought this phrase might mean to the patient.
“The patient,” he queried, “what does that have to do with it?”  I was frustrated, somewhat aghast that this third-
year student, steeped in patient-centered interviewing throughout his first two years of school, missed that the patient 
had something to do with their own care and that the phrase “my patient” might claim ownership of another person or 
their attributes, such as soul, physical being, or responsibilities…
I asked him, “Who is responsible for the patient’s care?”
“I am,” he responded quickly.  Specifically relating the discussion to patient autonomy from his clinical skills 
training, he voiced some understanding that the hypothetical patient shared some responsibility for her care, but could 
not imagine this actual patient playing a chief role in their well-being as he felt that was his role as the physician-in-
training.
I left the discussion unsatisfied and shared the interaction with a fellow health educator that evening. She said that 
as a social worker it was important to avoid this phrase because it meant that person is the only person responsible for 
the patient’s care, negating the patient’s ownership for her care as well as the interprofessional team members working 
to improve the patient’s well-being, such as the social worker, nurse, dietitian, and physical therapist.
I then discussed “my patient’ with residency faculty.  One physician detailed orienting residents that the patients 
were their patients rather than her patients, impressing on residents that they were responsible for the patient’s care, 
not her.  “My patient” represented accountability and ownership of the role of physician.
Not long after the “my patient” interaction in clinic, I said goodbye to my patients. Yes, “my patients!”  I had 
been seeing some of them for 10 years; it was difficult to say goodbye. I completely accepted responsibility for my 
part of their care and strived to not claim responsibility for their roles.  These patients were a part of my life. It felt 
incomplete and disrespectful to call them “the patients” rather than “my patients.”  I think this was a way of honoring 
our relationship.  It felt uplifting to put to words this connection to another human being, however humble it may be.  
I felt like I’ve come full circle, from ownership to relationships.
I think this phrase, “my patient,” has struck me so because of this value of connecting to others.  Just as I 
encouraged the student to open his mind to other meanings, I can open my mind to the intricacies of our language.  
I love that I can continue to evolve as a physician, educator, and person.  As much as possible, my goal now is to 
empower the patient by helping them to take ownership for their care and well-being and to empower the learner to 
be the patient advocate as well as empowerer.  I want to empower patients to take responsibility for their well-being, 
their care, their bodies, their selves.
*Dr. Minor is the Director of Clinical Faculty Development and an Associate Professor at the Florida International 
University Herbert Wertheim College of Medicine.
By Suzanne Minor, MD, FAAP*
6  Mid-Atlantic Ethics Committee Newsletter
HORIZON FOUNDATION ANNOUNCES HOWARD COUNTY 
SPEAK(EASY) PROGRAM
This article was adapted from a press release available at: http://www.thehorizonfoundation.org/horizon-
foundation-announces-speakeasy-howard-campaign/. 
The Horizon Foundation has announced the launch of Speak(easy) Howard, a new campaign that aims to encourage 
Howard County residents to take two critical first steps in planning for end-of-life care: have a conversation about 
health care wishes with loved ones and identify a health care proxy who can communicate these wishes. The campaign 
kicked off June 23, 2016 with the launch of a community collaborative made up of nearly a dozen organizations. 
Collaborative participants—including faith groups, health care providers, community centers and others—will commit 
one year to learning and implementing best practices in end-of-life care planning. The collaborative will receive 
guidance and support from experts with The Conversation Project and the Institute for Healthcare Improvement. In 
2017, the Horizon Foundation will launch a countywide outreach and promotion campaign for Speak(easy) Howard 
to expand the collaborative’s efforts to all individuals in Howard County. An important goal is to increase the number 
of people who have designated their health care proxy, a trusted person who will make health care decisions if they 
are unable to communicate those decisions themselves. Another important goal of this effort is to ensure doctors can 
connect with chosen health care proxies and learn each person’s care decisions so these wishes can be respected. 
Horizon is partnering with the Howard County government and Maryland’s official health information exchange, 
Chesapeake Regional Information System for our Patients (CRISP), to establish an electronic registry that will allow 
individuals to designate their health care proxy online, and have that information easily accessible by hospital and 
medical providers statewide. For more information, visit http://speakeasyhoward.org/. 
HOPKINS PERFORMS FIRST HIV+ TO HIV+ ORGAN 
TRANSPLANT
Last Spring, Hopkins 
performed a first 
in organ transplant 
medicine: an HIV-
positive dead donor 
provided a liver and 
kidney to two HIV-positive recipients. 
Transplanting organs from HIV-
positive donors was banned in the 
U.S. in 1984. Over the years, concerns 
escalated about the lack of ethical 
justification for letting HIV-positive 
patients awaiting an organ transplant 
die when they could safely receive an 
organ from an HIV-positive donor. 
The 2013 HIV Organ Policy Equity 
(HOPE) Act, signed in 2013, ended 
the ban on using HIV-positive donor 
organs. However, it took another three 
years before the United Network for 
Organ Sharing (UNOS) approved 
the first hospital to conduct such 
transplants. That honor went to 
Hopkins, perhaps in part due to 
the advocacy of Hopkins surgeon 
Dorry Segev in getting the HOPE 
Act drafted and passed (Cohn, 
2016). Given breakthroughs in 
anti-viral medications to suppress 
the HIV virus, most HIV-positive 
donors have sufficiently low viral 
loads to make donation safe for an 
HIV-positive recipient. Transplantation 
of an organ from an HIV-positive 
donor into an HIV-positive individual 
will be done under a research protocol 
requiring, among other things, that 
the donor and recipient be on similar 
anti-viral drug regimens. Research 
protocols are currently being 
developed to allow living HIV-positive 
individuals to donate organs to other 
HIV-positive individuals. Providing 
these transplants under research 
protocols will allow comparison 
of outcomes between HIV-positive 
individuals transplanted with organs 
with and without prior exposure to 
the HIV virus. One concern is that the 
organ recipient could contract a more 
aggressive strain of the HIV virus, 
but the criteria for matching donor 
and recipient incorporates safeguards 
to minimize this risk. Although the 
number of HIV-positive donors will 
remain relatively small in the near 
future, it will grow over time, and will 
effectively shorten organ wait times 
for everyone. 
REFERENCES
Cohn, M. (March 30, 2016). Johns 
Hopkins performs first transplants 
between donors, recipients infected with 
HIV. The Baltimore Sun, Available at 
http://www.baltimoresun.com/health/bs-
hs-hiv-transplant-20160329-story.html. 
Mid-Atlantic Ethics Committee Newsletter  7
JAHI MCMATH UPDATE
In December, 2013, then-thirteen year old Jahi McMath was pronounced dead after physical exams and 
confirmatory criteria indicated irreversible cessation of brain function. Her family sought legal intervention to 
maintain Jahi on ventilator support, along with artificial nutrition/hydration. Her body was ultimately moved across 
country from California, and currently resides in a facility in New Jersey, which allows an exemption from declaration 
of death based on neurologic criteria for those who have a religious belief that if a person’s heart is still beating, the 
person is still alive. Jahi’s parents claim to have new evidence that Jahi has brain function precluding a brain death 
determination. 
Complaints filed by the McMath family in a medical malpractice action against Oakland Children's hospital include 
opinions from a pediatrician with expertise in brain death who reviewed Jahi’s medical records, magnetic resonance 
imaging (MRI) and magnetic resonance angiography (MRA) scans done in September, 2014 (about 10 months after 
Jahi’s anoxic brain injury), and 22 videotapes of Jahi’s movements. The pediatric neurologist concluded that Jahi 
does not meet brain death criteria. Specifically, the MRI reportedly showed vast areas of the brain that are structurally 
preserved (including areas in the cerebral cortex, basal ganglia and cerebellum), and the MRA showed intracranial 
blood flow. Moreover, Jahi reportedly underwent menarche and developed breasts since her brain injury. If this 
were true, it would demonstrate hormonal interaction between the hypothalamus, pituitary gland, and ovaries that 
demonstrates some level of brain function. Lastly, Jahi is reportedly able to respond intentionally at times to verbal 
commands (Pope, n.d.). Those doubting the assertion that Jahi does not now meet brain death criteria point out that 
the scans and videotapes have not been released for others to view, and that she may well have reached menarche 
before her injury (i.e., continued menstruation after a brain death determination does not signify brain function at 
odds with a brain death diagnosis). Given that confirmatory testing initially done (and repeated 
before Jahi’s transfer out of California) indicated that Jahi had irreversible and complete loss of 
brain function and thus met legal criteria for death, if new data reveal otherwise, this may have 
widespread implications for how death is defined in the U.S. and elsewhere. 
REFERENCE
Pope, T. (n.d.). Jahi McMath: A Dispute over Brain Death. Available at http://www.thaddeuspope.com/jahimcmath.html. 
NIH'S CENTERS OF EXCELLENCE IN PAIN EDUCATION 
(COEPE) MODULES
The National Institutes of Health 
Pain Consortium has funded 11 
health professional schools as 
designated Centers of Excellence 
in Pain Education (CoEPEs). The 
CoEPEs will develop, evaluate, 
and distribute pain management 
curriculum resources for schools 
training health care professionals 
(including medical, dental, nursing, 
and pharmacy schools). The awardees 
are University of Alabama at 
Birmingham, University of California, 
San Francisco, Harvard University, 
University of Connecticut, University 
of Iowa, Johns Hopkins University, 
University of Pennsylvania, 
University of Pittsburgh, University 
of Rochester, Southern Illinois 
University Edwardsville, and the 
University of Washington. 
The first CoEPE module, released 
July 20, 2016 from the University of 
Pittsburgh, features a case study of 
“Edna,” an older adult with chronic 
low back pain. (To access this and 
other CoEPE modules, visit https://
painconsortium.nih.gov/NIH_Pain_
Programs/CoEPES.html.)  Sponsors 
of NIH’s Pain Consortium include the 
National Institute on Drug Abuse, the 
National Center for Complementary 
and Integrative Health, the National 
Institute of Dental and Craniofacial 
Research, the National Institute 
of Nursing Research, the National 
Institute of Neurological Disorders 
and Stroke, the Office of Behavioral 
and Social Sciences Research, and 
the Office of Research on Women’s 
Health. 
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COMMENTS FROM ETHICS 
COMMITTEE MEMBERS
   This case demonstrates what 
happens with families in hospitals 
every day. Medical decision making 
can be extremely difficult when there 
are differences in opinion among 
family members and little or no 
previous discussions have taken place 
to communicate wishes. Uncertainty 
frequently happens and this case is the 
perfect example of why care planning 
is so important and how hospital 
ethics committee members facilitate 
conversations and collaborate with 
families to assist them in medical 
decision making. Since Mrs. R, a 
widow, does not have an advance 
directive, Maryland surrogacy law 
dictates that her children have equal 
say in all decision making (https://
www.oag.state.md.us/Healthpol/
HCDA.htm).
   In this case, there are at least four 
competing perspectives regarding 
treatment, the clinical team, Mrs. R 
and her two children. What does each 
perspective believe is the best for Mrs. 
R.? For the clinical team, a treatment 
plan which promotes beneficence 
while avoiding maleficence. For 
Mrs. R., in the absence of an advance 
directive, it is difficult to assess her 
true perspective. This leads to the 
competing and complex perspective of 
her two children. Her son articulates 
his belief that she would want a 
lively quality of life not dependent on 
machines while her daughter expects 
her mother to fight to live at all costs. 
These competing narratives warrant 
open discussion and examination.
In a patient and family centered model 
of care, it is critically important that 
a family meeting be conducted which 
would provide an opportunity for the 
expression and discussion of these 
competing perspectives. Since the goal 
for this meeting is to help the children 
facilitate a plan of care for their 
mother, it is important for the clinical 
team to review Mrs. R.’s illness with 
the family and to address the risks, 
benefits and probable outcome(s) 
for Mrs. R. and to answer any of the 
children’s questions. 
   This supportive conversation would 
include the patient’s advanced age 
and medical history, her current 
condition, current and proposed 
interventions including details about 
the tracheostomy, ventilator, and 
feeding tube. It is also paramount that 
members of the clinical team are able 
to address specific questions regarding 
care, treatment and potential prognosis 
in a manner that family members can 
understand. 
   After the medical information is 
presented, the discussion would move 
to other aspects of the patient’s values, 
beliefs and spiritual background. This 
helps frame the difficult question of 
quality of life for someone who can 
no longer speak for herself. With 
this framework, her children would 
then be encouraged to express their 
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an 
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit 
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the 
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify 
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to  
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey 
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
CASE PRESENTATION
CASE STUDY FROM A TERTIARY CARE HOSPITAL
Mrs. R. is a 96 year old female who was admitted from home to a community hospital with pneumonia. She was living 
at home before that with increasing assistance from paid caregivers. There, she was treated in the community hospital's 
ICU for three days before being transferred to a larger hospital, where she remains intubated in the ICU, on a ventilator, 
non-communicative. She has a feeding tube in place and is transitioning to intermittent dialysis from continuous dialysis 
to manage her high blood volume. Her blood pressure is being supported by medication. General surgery is consulted 
to assess for tracheostomy placement. Mrs. R has a living son (K, who lives in state) and a daughter (H, who lives in a 
distant state) involved in her care. H. wants to maintain life support and is in favor of the trach. She believes her mother 
is a fighter and would want to live. K. disagrees. He states that while his mother never discussed end-of-life preferences 
with them, and didn't complete an advance directive, she did not like to see people in wheelchairs, and was uncomfortable 
when her husband spent time in the nursing home (he died 4 years prior). K. describes his mother as "lively," she enjoyed 
casinos, going out, and keeping her appearance. He feels confident that "she would never want to live like this hooked up 
to all these machines." But to avoid conflict, he defers to H's wishes.  The team thinks it's nearly certain that Mrs. R. will 
not leave the ICU. The surgical team requests an ethics consultation to inform whether they should proceed with the trach.
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thoughts and feelings and to identify 
areas of agreement and disagreement 
with respect to their mother’s quality 
of life. The family meeting would 
include the opportunity for Mrs. 
R.’s children to discuss amongst 
themselves, and with any other family 
they would like to include, the options 
for this patient. It is not unusual after 
a family meeting for a follow up 
conversation to address any questions 
that may have come out of the first 
meeting. The result of this meeting 
would hopefully lead to an agreement 
between both children on how to 
proceed with the patient’s medical 
care. 
   Unfortunately, not all families come 
to an agreement even with extensive 
discussions. While not completely 
the scope of this current response, if 
disagreement persisted, several new 
questions would arise. One issue 
would be if one of the children agreed 
to abdicate their right for equal say in 
decision making, the other child could 
become the patient’s sole surrogate 
decision maker. Clear documentation 
of an affidavit of surrogacy should 
then be done and care would proceed 
based on that child’s decisions. 
Another outcome of a disagreement 
could be the failure of either child to 
forgo their decision making right. This 
would likely require more in-depth 
conversations and family meetings. If 
disagreement persisted, petitioning for 
guardianship could be done to allow 
the courts to weigh in on who should 
be guardian. This process can be 
onerous and lead to further acrimony 
among family members. Finally, 
if clinical teams fundamentally 
disagree with decisions that have 
been made in a patient’s plan of care, 
documentation and discussions of 
futility may happen. The concept of 
medically ineffective treatment, i.e. 
futility, is incorporated in Maryland 
law (Sabatino, 2010), and informed by 
ethical guidelines (Bosslet et al, 2015; 
Kon et al., 2016). Families must still 
be included in these discussions and 
have to be notified of the decision to 
withhold or withdraw treatment based 
on futility.
University of Maryland Upper 
Chesapeake Health Ethics 
Committee Members:
Karen Goodison, MS, 
RRT-NPS, RPFT
Jamie Kelly, LCSW
Angela Poppe Ries, MD
Allen Siegel, OFS, MA 
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COMMENTS FROM A 
PHYSICIAN ETHICS 
COMMITTEE CHAIR
   The immediate question being 
asked regarding tracheostomy is 
really fairly straightforward, but 
there are much larger issues lurking 
in the background. In my opinion, 
looking at the question through the 
eyes of a recovering adult intensivist, 
the question of tracheostomy can 
be answered from a straightforward 
medical risk-benefit viewpoint, 
based on the ethical principles of 
beneficence and non-maleficence. The 
endotracheal tube which is already in 
place is an acceptable way to maintain 
mechanical ventilation. While “early 
trach” is sometimes recommended 
for a variety of reasons, it is not 
mandatory. Since the patient is not 
expected to survive the ICU stay, it 
is difficult to justify trach as being 
beneficial at all, and there certainly are 
risks to the procedure. Thus, it seems 
medically prudent to maintain a wait 
and see attitude, as tracheostomy may 
never be required if the patient dies of 
her underlying disease process within 
the next few weeks. Time is also 
gained for potential resolution of the 
underlying end-of-life issues. 
   The larger issue is how did R wind 
up on invasive life support measures 
in the first place, and why is there 
dispute about her wishes regarding 
end of life care? Rather than limit 
our opinion to placement of the 
tracheostomy, I believe it is imperative 
to question the current course of 
treatment R is enduring.  We know 
that R and her children never had 
“The Conversation.”  Apparently 
she never had it with her physician 
either, although we are not specifically 
told that her primary doctor was 
appropriately contacted—something 
that seems to get overlooked 
more and more in our fragmented 
medical delivery system. Clearly 
the uncertainty about R’s wishes 
represents a failure on many levels, 
not just medical. If she filled out a 
financial will, why didn’t her lawyer 
introduce a medical directive too? 
We freely talk about how to spend 
down assets or distribute someone’s 
possessions after they die, so why 
not how they want to spend their last 
days?  Religious communities can also 
do a better job at facilitating end of 
life conversations with families. 
   Since there is no advance directive 
or medical agent named, R’s children, 
since her spouse is dead, are now her 
surrogates and each has equal power 
under the law. Unfortunately, it is 
common that there is disagreement 
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between children as in this case.  
Her son, K, provides insight into his 
mother’s personality, believes his 
mother would not want to die this 
way, and does not want to proceed 
with tracheostomy. His sister H, 
however, claims that her mother is 
a fighter and wants to proceed with 
tracheostomy. In order to keep peace 
in the family, K is deferring to H, as 
is his right. One can only speculate 
about the psychologic dynamics 
leading to their difference in opinion.  
   As tracheostomy is medically 
unnecessary at this time, why 
were the children asked to provide 
informed consent for this procedure? 
We can only speculate that H has 
also informed the medical team 
that R is to be a full code, and the 
medical team is now asking, probably 
by reflex instead of reasoning, for 
tracheostomy (the ritual of PEG 
tube placement having already been 
performed). To be clear, even if R 
is a full code at the moment, there 
is no ethical obligation to offer 
non-beneficial treatment and in my 
opinion consent for a trach should not 
have been requested.  
   We have now reached the point 
where we must discuss autonomy.  
There seems to be a common 
perception in our society that 
autonomy means that a patient, or 
surrogate, has the right to determine 
what treatments will be given, 
and many physicians think they 
are required to offer all possible 
treatments, not just those that would 
be beneficial to the patient.  This is 
one of the root causes of many of the 
dilemmas clinicians face especially 
when treating patients at end of life. 
Rather than the right to determine 
what treatments will be given, 
autonomy is the right of the patient 
to say “don’t do that to me.”  It is 
the right to say what you don’t want 
done to your body, and is the ethical 
basis for the entire informed consent 
process.  
   Some may fear that such an 
interpretation of patient autonomy 
places us on the slippery slope to 
paternalism.  However, I believe this 
interpretation is entirely consistent 
with the current acceptance of 
“shared decision-making” as the 
model for determination of goals of 
care. In too many cases, however, 
the physician’s share of the decision 
is almost totally subordinate to the 
patient or surrogate. The above 
interpretation of autonomy should 
help even this balance.  
   Now that tracheostomy has 
been deferred, it is time to resume 
negotiations with the family regarding 
goals of care. We have not been told 
if Palliative Care has been involved; 
if not, they should be consulted to 
present their recommendations and 
how they would care for R. Perhaps 
there are other family members or 
friends who would be willing to 
participate and share their perceptions 
of what R would want given her 
current condition. During the family 
meeting, which hopefully H will be 
able to attend in person so she can see 
her mother, I would review the ethical 
principles involved, including the 
physician’s obligation to advocate, 
first and foremost, for their patient, 
and to alleviate suffering, not cause 
it.  We need to make it clear to H 
that withholding non-beneficial 
treatments that simply prolong the 
dying process does not mean that 
we are withholding care. I would 
inform H that R’s physicians do not 
expect R to survive the ICU stay 
even with the invasive treatments 
being provided. Therefore, these 
treatments are inherently non-
beneficial and medically ineffective, 
as they will not prevent the death 
of the patient from her underlying 
disease but only prolong R’s death 
and suffering, violating the principle 
of non-maleficence. I would speak of 
autonomy as the right of the surrogate 
to put limitations on treatments 
they think R would not want in her 
current condition, but not the right to 
require non-beneficial and harmful 
treatments be given. The medical 
team should present the treatment 
options that they believe can benefit 
and provide proper care for R, as well 
as their recommendations. In this 
way, surrogates can choose between 
medically and ethically acceptable 
treatments. 
   In the course of such negotiations, 
questions of withdrawal and 
withholding occur. While withdrawal 
and withholding are considered 
ethically and legally the same, 
emotionally they are quite different. 
If withdrawal is more than the family 
or surrogate can bear, compromises, 
such as no escalation of life-
sustaining treatments including no 
CPR, may be warranted. While not an 
ideal resolution, as patient suffering 
can still be prolonged, it certainly 
provides some limits on medically 
ineffective treatments which would 
otherwise be given. 
   If negotiations fail, the last recourse 
is to use the process stipulated in the 
Health Care Decisions Act to declare 
specific treatments to be medically 
ineffective.  It is beyond the scope 
of this commentary to review this 
process, other than to say it is an 
option with which our physicians and 
ethics committees should be familiar. 
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Advancing Public Policy to Recognize and Support Family Caregivers. Sponsored by the Geriatrics and Gerontology 
Education and Research Program and UM partners. Contact: rcornman@umaryland.edu.
20 (5:30-7P) 
2016 Presidential Election Panel: The Affordable Care Act: Too Big to Fail? Sponsored by the Law & Health Care 
Program, Maryland Carey Law, Ceremonial Moot Court Room, 500 West Baltimore St., Baltimore, MD. For more 
information, contact vrowthorn@law.umaryland.edu. 
20 
Recovering Inside? Ethical Challenges in Correctional Mental health Care. Sponsored by the Department of Medical 
Ethics & Health Policy, University of Pennsylvania, Philadelphia, PA. Visit: http://medicalethics.med.upenn.edu/
events/2016/10/20/recovering-inside-ethical-challenges-in-correctional-mental-health-care 
24 (12-1:15P) 
Johns Hopkins Berman Institute of Bioethics Seminar Series. Speaker: Susan Goold, MD, Professor of Internal Medicine 
(School of Medicine) & Health Management and Policy (School of Public Health), University of Michigan.  Feinstone 




Challenges in Organ Donation & Transplantation, Third Interprofessional Forum on Ethics and Religion in Health Care. 
Sponsored by the Institute for Jewish Continuity and UM Schools of Dentistry, Medicine, Law (MHECN), Nursing, 
Pharmacy, and Social Work. Visit: http://www.law.umaryland.edu/mhecn. 
4-7
Clinical Ethics Immersion, Sponsored by the Center for Ethics at MedStar Washington Hospital Center, Washington, DC. 
Visit: http://www.medstarwashington.org/our-hospital/center-for-ethics/clinical-ethics-immersion/#q={}. 
11-12
The 28th Annual Dorothy J. MacLean Fellows Conference on Clinical Medical Ethics, University of Chicago Law School, 
Chicago, IL. Visit: http://MacLeanConference2016.eventbrite.com. 
14-16
Bioethical Challenges in Neurogenomics from an Interreligious and Multicultural Perspective. Sponsored by MD Anderson 
Cancer Center, Houston, Texas. For more information, contact cmgallagher@mdanderson.org. 
28
Johns Hopkins Berman Institute of Bioethics Seminar Series. Speaker: Bob Arnold, MD, Professor of Medicine, Chief, 
Section of Palliative Care and Medical Ethics, Director, Institute for Doctor-Patient Communication, University of 
Pittsburgh.  Chevy Chase Conference Center, Sheik Zayed Tower, Johns Hopkins Hospital, Baltimore, MD. Visit: http://
www.bioethicsinstitute.org/education-training-2/seminar-series. 
28
Johns Hopkins Berman Institute of Bioethics Seminar Series. Speaker: Kimani Paul-Emile, PhD, JD, Associate Professor 
of Law, Fordham University School of Law.  Chevy Chase Conference Center, Sheik Zayed Tower, Johns Hopkins 
Hospital, Baltimore, MD. Visit: http://www.bioethicsinstitute.org/education-training-2/seminar-series.
DECEMBER 
12
Johns Hopkins Berman Institute of Bioethics Seminar Series. Speaker: John Wilbanks, Chief Commons Officer, Sage 
Bionetworks.  Chevy Chase Conference Center, Sheik Zayed Tower, Johns Hopkins Hospital, Baltimore, MD. Visit: http://
www.bioethicsinstitute.org/education-training-2/seminar-series.
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